Skip to main content

Amyotrophic Lateral Sclerosis Care in Tunisia

  • Chapter
  • First Online:
Public Policy in ALS/MND Care
  • 188 Accesses

Abstract

Amyotrophic lateral sclerosis (ALS) is rare in Tunisia, where access to new etiopathogenic treatment is still limited. In this review, we examine the existing model of care for ALS patients in Tunisia, the law that governs ALS care and how multidisciplinary care is delivered. We also shed light on the clinical particularity of Tunisian ALS patients. We believe that funding challenges for ALS care, improvement of ALS awareness and increased knowledge for ALS management are required. The current challenges of ALS in Tunisia are to ensure coordinated interprofessional care and establish an interdisciplinary model care for people with ALS and their family caregivers as key stakeholders and decision markers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Achour, N. (2011). Le systeme de sante tunisien: Etat des lieux et defis. http://www.unfpa-tunisie.org. (Article in French).

  • Alkire, B.C. (2015). Global access to surgical care: A modelling study. The Lancet Global Health 3 (6): e316–e323.

    Article  Google Scholar 

  • Ben Hamida, M. (1990). Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain 113: 347–63.

    Google Scholar 

  • Ben Hamida, M. and F. Hentati (1984). Maladie de Charcot et sclérose latérale amyotrophique juvénile. Revue Neurologique (Paris) 140 (3): 202–206.

    Google Scholar 

  • Beghi, E. (2006). The epidemiology of ALS and the role of population-based registries. Biochimica et BiophysicaActa (BBA)-Molecular Basis of Disease 1762 (11–12): 1150–57.

    Article  Google Scholar 

  • Bali, T. and T.M. Miller (2013). Management of amyotrophic lateral sclerosis. Missouri Medicine 110 (5): 417–21.

    Google Scholar 

  • Brooks, B., D. Lewis and J. Rawling (1994). The natural history of amyotrophic lateral sclerosis. Motor Neuron Disease, A.C. Williams, ed. London: Chapman & Hall Medical, 131–69.

    Google Scholar 

  • Buckman, R. (1984). Breaking bad news: why is it still so difficult? British Medical Journal (Clinical research ed.) 288 (6430): 1597–99.

    Google Scholar 

  • Dharmadasa, T. (2016). Treatment approaches in motor neurone disease. Current Opinion in Neurology 29 (5): 581–91.

    Article  Google Scholar 

  • Gauthier, A. (2007). A longitudinal study on quality of life and depression in ALS patient–caregiver couples. Neurology 68 (12): 923–26.

    Article  Google Scholar 

  • Güell, M.R. (2013). Comprehensive care of amyotrophic lateral sclerosis patients: A care model. Archivos de Bronconeumología (English Edition) 49 (12): 529–33.

    Article  Google Scholar 

  • Hentati, A. (1994). Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35. Nature Genetics 7 (3): 425–28.

    Article  Google Scholar 

  • Hogden, A. (2015). Development of a model to guide decision making in amyotrophic lateral sclerosis multidisciplinary care. Health Expectations 18 (5): 1769–82.

    Article  Google Scholar 

  • Hogden, A. (2017). Amyotrophic lateral sclerosis: Improving care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare 10: 205–15.

    Google Scholar 

  • Jennum, P. (2013). Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: A controlled national study. Journal of Neurology 260 (3): 785–93.

    Article  Google Scholar 

  • Kacem, I., I. Sghaier, S. Bougatef, A. Nasri et al. (2019). Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration: https://doi.org/10.1080/21678421.2019.1704012.

  • Knoppers, B.M. (2006). The emergence of an ethical duty to disclose genetic research results: International perspectives. European Journal of Human Genetics 14 (11): 1170–78.

    Google Scholar 

  • Logroscino, G. (2018). Global, regional, and national burden of motor neuron diseases 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 17 (12): 1083–97.

    Article  Google Scholar 

  • Luna, J. (2019). Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: The TROPALS study. Journal of Neurology, Neurosurgery and Psychiatry 90 (1): 20–29.

    Article  Google Scholar 

  • Mayadev, A.S. (2008). The amyotrophic lateral sclerosis center: A model of multidisciplinary management. Physical Medicine and Rehabilitation Clinics of North America 19 (3): 619–31.

    Article  Google Scholar 

  • Marin, B. (2012). Juvenile and adult-onset ALS/MND among Africans: Incidence, phenotype, survival: a review. Amyotrophic Lateral Sclerosis 13 (3): 276–83.

    Article  Google Scholar 

  • Mitsumoto, H. (2007). A strategy to develop effective ALS therapy. Brain and Nerve= Shinkeikenkyu no shinpo 59 (4): 383–91.

    Google Scholar 

  • Makhloufi, K. (2015). Have health insurance reforms in Tunisia attained their intended objectives? International Journal of Health Economics and Management 15 (1): 29–51.

    Article  Google Scholar 

  • Ozanne, A.G.O. (2011). Quality of life, anxiety and depression in ALS patients and their next of kin. Journal of Clinical Nursing 20 (1–2): 283–91.

    Article  Google Scholar 

  • Peters, D.H. (2008). Poverty and access to health care in developing countries. Annals of the New York Academy of Sciences 1136 (1): 161–71.

    Article  Google Scholar 

  • Santaniello, B. (2018). ALS managed care considerations. The American Journal of Managed Care 24 (15 Suppl): S336–S341.

    Google Scholar 

  • Scott, A. (2017). Drug therapy: On the treatment trail for ALS. Nature 550 (7676): S120.

    Article  Google Scholar 

  • Steen, I.V.D. (2009). The costs of amyotrophic lateral sclerosis, according to type of care. Amyotrophic Lateral Sclerosis 10 (1): 27–34.

    Article  Google Scholar 

  • UNESCO Institute for Statistics (2018). http://uis.unesco.org/

  • Zoccolella, S. (2007). Riluzole and amyotrophic lateral sclerosis survival: A population-based study in southern Italy. European Journal of Neurology 14 (3): 262–68.

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to express their thanks to multidisciplinary ALS Tunisian team: Prof. Dziri Catherine (Head of Department of Medicine Physical and Functional Rehabilitation of the National Institute of Orthopaedics “M.T. Kassab,” Tunisia), Prof. Trabelsi Samah (Head of National Pharmacovigilance Center, Tunisia), Prof. Brahmi Nozha (Head of Department of Intensive Care and Toxicology, Montfleury, Tunisia) and Prof. Kallel Lamia (Head of Gastroenterology Department, Mahmoud El Matri Hospital, Tunisia) for their excellent assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Riadh Gouider .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kacem, I., Sghaier, I., Nasri, A., Gouider, R. (2021). Amyotrophic Lateral Sclerosis Care in Tunisia. In: Blank, R.H., Kurent, J.E., Oliver, D. (eds) Public Policy in ALS/MND Care. Palgrave Macmillan, Singapore. https://doi.org/10.1007/978-981-15-5840-5_20

Download citation

Publish with us

Policies and ethics